Dark Forest Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Dark Forest Capital Management LP
- $2.02 Billion
- Q1 2025
A detailed history of Dark Forest Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Dark Forest Capital Management LP holds 32,464 shares of BCRX stock, worth $284,384. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,464
Previous 29,693
9.33%
Holding current value
$284,384
Previous $223,000
8.97%
% of portfolio
0.01%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
294Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$190 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$175 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$78.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$76.2 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$68.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.63B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...